Currently Viewing:
ADA 2013
NOW AVAILABLE: ADA 2013 Conference Coverage
August 16, 2013
Impact of Quality Care Measures on Patient Care
June 25, 2013
Non-Glycemic Effects of Glucagon-Like Peptide-1 Agonists and Dipeptidyl Peptidase-4 Inhibitors
June 25, 2013
Pharmacotherapy for Obesity: Filling a Therapeutic Gap
June 25, 2013
Ronald J. Sigal, MD, MPH, Discusses the Reality of Exercise and Physical Activity Goals for Most Patients
June 24, 2013
Currently Reading
Philip R. Schauer, MD, Shares His Thoughts on the Necessary Direction of Accountable Care Organizations
June 24, 2013
Todd Brusko, PhD, Remarks on Evolving Role of Immunoregulation in Type 1 Diabetes
June 24, 2013
Allan Geliebter, PhD, Discusses the Impact of Bariatric Surgery on Hormone Regulation and Neurological Response
June 24, 2013
Novel SGLT-2 Inhibitors: The Impact on Outcomes in Diabetes and Cardiovascular Health
June 23, 2013
Connecting the Dots: Global Epidemiology of Type 1 Diabetes and National Income Levels
June 23, 2013
Sheldon Greenfield, MD, Discusses Integrating Quality Care Measures into Diabetes Management: Two Sides of the Coin
June 23, 2013
Rita Basu, MD, Discusses The Role of Testosterone Supplementation in Men with Diabetes
June 23, 2013
Diabetes Cost-Effectiveness Studies and How They Affect Real-World Treatment
June 22, 2013
Sandeep Dhindsa, MD:The Chicken or the Egg: Which Comes First, Diabetes or Low Testosterone in Men?
June 22, 2013
Andrew J. Palmer, MD: Allocating Resources Effectively for Patients in the United States and Around the World
June 22, 2013
Jaakko Tuomilehto, MD, PhD, Discusses The Link Between Type 1 Diabetes Mellitus and a Nation's Socioeconomic Status
June 22, 2013

Philip R. Schauer, MD, Shares His Thoughts on the Necessary Direction of Accountable Care Organizations

Philip R. Schauer, MD, the director of the Bariatric and Metabolic Institute (BMI) at the Cleveland Clinic in Ohio contends that accountable care organizations (ACOs) need to recognize obesity as a legitimate disease that is the basis for many other serious conditions. He emphasizes that obesity certainly requires treatment, and surgery is an appropriate intervention for certain patients.


Philip R. Schauer, MD, the director of the Bariatric and Metabolic Institute (BMI) at the Cleveland Clinic in Ohio contends that accountable care organizations (ACOs) need to recognize obesity as a legitimate disease that is the basis for many other serious conditions. He emphasizes that obesity certainly requires treatment, and surgery is an appropriate intervention for certain patients.

This video was taken at the American Diabetes Associations 73rd Scientific Sessions in Chicago, IL.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!